We are a firm built upon strong focus on the patient at the center of everything that we do. Apexian has a dynamic culture, which supports our commitment to patients. From the beginning as our founder, Mark Kelley, PhD, worked to identify potential molecules that would impact the APE1/Ref-1 biology, we have sought to develop relationships that are built upon mutual respect and aimed at addressing some of the most difficult cancers that still cut lives short in our world. Read more about who we are and how the Apexian family is working to find solutions to develop transformational products for patients.

Leadership Team

Board of Directors

Scientific Advisory Board